Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
1件: RARA 💬 Vitamin A 💬 Vitamin A 3件: 13, 53, 90 💬
2 Adrenergic signaling in cardiomyocytes 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
3 AGE-RAGE signaling pathway in diabetic complications 💬
2件: VEGFA, VEGFB 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
4 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
5 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
6 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
7 Alcoholism 💬
2件: DRD1, DRD2 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
8 Aldosterone synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
9 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
10 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
11 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
12 Alzheimer disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
13 Amphetamine addiction 💬
2件: CACNA1C, CACNA1D 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
14 Amphetamine addiction 💬
1件: DRD1 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
15 Arrhythmogenic right ventricular cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
16 beta-Alanine metabolism 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
17 beta-Alanine metabolism 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
18 beta-Alanine metabolism 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
19 Bile secretion 💬
1件: CA2 💬 Acetazolamide 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
20 Bile secretion 💬
1件: CA2 💬 Acetazolamide sodium 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
21 Bile secretion 💬
1件: CA2 💬 Dorzolamide hydrochloride 💬 Dorzolamide 1件: 90 💬
22 Bile secretion 💬
1件: CA2 💬 Dorzolamide 💬 Dorzolamide 1件: 90 💬
23 Bladder cancer 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
24 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
25 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
26 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
27 Calcium signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
28 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
29 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
30 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
31 Calcium signaling pathway 💬
2件: DRD1, DRD5 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
32 Calcium signaling pathway 💬
1件: PTGFR 💬 Isopropyl unoprostone 💬 Unoprostone 1件: 90 💬
33 Calcium signaling pathway 💬
1件: PTGFR 💬 Unoprostone 💬 Unoprostone 1件: 90 💬
34 Calcium signaling pathway 💬
2件: VEGFA, VEGFB 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
35 cAMP signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
36 cAMP signaling pathway 💬
3件: DRD1, DRD2, DRD5 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
37 Carbohydrate digestion and absorption 💬
1件: CACNA1D 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
38 Cardiac muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
39 Cellular senescence 💬
1件: CACNA1D 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
40 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Brimonidine tartrate 💬 Brimonidine 2件: 13, 90 💬
41 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Brimonidine 💬 Brimonidine 2件: 13, 90 💬
42 cGMP-PKG signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
43 Chemical carcinogenesis - reactive oxygen species 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
44 Chemical carcinogenesis - receptor activation 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
45 Chemical carcinogenesis - receptor activation 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
46 Cholinergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
47 Circadian entrainment 💬
2件: CACNA1C, CACNA1D 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
48 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
49 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
50 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
51 Circadian entrainment 💬
2件: MTNR1A, MTNR1B 💬 Melatonin 💬 Melatonin 17件:  2 ,  6 ,  8 , 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202, 265 💬
52 Cocaine addiction 💬
2件: DRD1, DRD2 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
53 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
54 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole sodium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
55 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole magnesium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
56 Collecting duct acid secretion 💬
1件: CA2 💬 Acetazolamide 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
57 Collecting duct acid secretion 💬
1件: CA2 💬 Acetazolamide sodium 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
58 Collecting duct acid secretion 💬
1件: CA2 💬 Dorzolamide hydrochloride 💬 Dorzolamide 1件: 90 💬
59 Collecting duct acid secretion 💬
1件: CA2 💬 Dorzolamide 💬 Dorzolamide 1件: 90 💬
60 Cortisol synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
61 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
62 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
63 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
64 Cushing syndrome 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
65 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
66 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
67 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
68 Dilated cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
69 Dopaminergic synapse 💬
2件: CACNA1C, CACNA1D 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
70 Dopaminergic synapse 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
71 Estrogen signaling pathway 💬
1件: RARA 💬 Vitamin A 💬 Vitamin A 3件: 13, 53, 90 💬
72 Fluid shear stress and atherosclerosis 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
73 Focal adhesion 💬
3件: PGF, VEGFA, VEGFB 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
74 GABAergic synapse 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
75 GABAergic synapse 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
76 GABAergic synapse 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
77 GABAergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
78 Gap junction 💬
2件: DRD1, DRD2 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
79 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
80 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole sodium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
81 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Omeprazole magnesium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
82 Gastric acid secretion 💬
1件: CA2 💬 Acetazolamide 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
83 Gastric acid secretion 💬
1件: CA2 💬 Acetazolamide sodium 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
84 Gastric acid secretion 💬
1件: CA2 💬 Dorzolamide hydrochloride 💬 Dorzolamide 1件: 90 💬
85 Gastric acid secretion 💬
1件: CA2 💬 Dorzolamide 💬 Dorzolamide 1件: 90 💬
86 Gastric cancer 💬
1件: RARB 💬 Vitamin A 💬 Vitamin A 3件: 13, 53, 90 💬
87 Glutamatergic synapse 💬
2件: CACNA1C, CACNA1D 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
88 GnRH secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
89 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
90 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
91 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
92 GnRH signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
93 Growth hormone synthesis, secretion and action 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
94 HIF-1 signaling pathway 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
95 Hormone signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Brimonidine tartrate 💬 Brimonidine 2件: 13, 90 💬
96 Hormone signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Brimonidine 💬 Brimonidine 2件: 13, 90 💬
97 Hormone signaling 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
98 Human cytomegalovirus infection 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
99 Human papillomavirus infection 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
100 Hypertrophic cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
101 Insulin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
102 Kaposi sarcoma-associated herpesvirus infection 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
103 Long-term potentiation 💬
1件: CACNA1C 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
104 MAPK signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
105 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
106 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
107 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
108 MAPK signaling pathway 💬
3件: PGF, VEGFA, VEGFB 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
109 MicroRNAs in cancer 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
110 Morphine addiction 💬
1件: DRD1 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
111 Neuroactive ligand signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Brimonidine tartrate 💬 Brimonidine 2件: 13, 90 💬
112 Neuroactive ligand signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Brimonidine 💬 Brimonidine 2件: 13, 90 💬
113 Neuroactive ligand signaling 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
114 Neuroactive ligand-receptor interaction 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Brimonidine tartrate 💬 Brimonidine 2件: 13, 90 💬
115 Neuroactive ligand-receptor interaction 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Brimonidine 💬 Brimonidine 2件: 13, 90 💬
116 Neuroactive ligand-receptor interaction 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
117 Neuroactive ligand-receptor interaction 💬
2件: MTNR1A, MTNR1B 💬 Melatonin 💬 Melatonin 17件:  2 ,  6 ,  8 , 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202, 265 💬
118 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Betamethasone 💬 Betamethasone 9件:  2 , 28, 46, 56, 65, 83, 90, 96, 235 💬
119 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Betamethasone sodium phosphate 💬 Betamethasone 9件:  2 , 28, 46, 56, 65, 83, 90, 96, 235 💬
120 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Betamethasone valerate 💬 Betamethasone 9件:  2 , 28, 46, 56, 65, 83, 90, 96, 235 💬
121 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Betamethasone acetate 💬 Betamethasone 9件:  2 , 28, 46, 56, 65, 83, 90, 96, 235 💬
122 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Betamethasone dipropionate 💬 Betamethasone 9件:  2 , 28, 46, 56, 65, 83, 90, 96, 235 💬
123 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Betamethasone benzoate 💬 Betamethasone 9件:  2 , 28, 46, 56, 65, 83, 90, 96, 235 💬
124 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Dexamethasone 💬 Dexamethasone 25件: 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
125 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Dexamethasone sodium phosphate 💬 Dexamethasone 25件: 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
126 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Dexamethasone phosphate 💬 Dexamethasone 25件: 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
127 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Fluocinolone acetonide 💬 Fluocinolone acetonide 1件: 90 💬
128 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Prednisone 💬 Prednisone 54件:  2 , 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
129 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Triamcinolone 💬 Triamcinolone 10件: 35, 46, 53, 56, 70, 90, 96, 107, 226, 298 💬
130 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Triamcinolone acetonide 💬 Triamcinolone 10件: 35, 46, 53, 56, 70, 90, 96, 107, 226, 298 💬
131 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Triamcinolone diacetate 💬 Triamcinolone 10件: 35, 46, 53, 56, 70, 90, 96, 107, 226, 298 💬
132 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Triamcinolone hexacetonide 💬 Triamcinolone 10件: 35, 46, 53, 56, 70, 90, 96, 107, 226, 298 💬
133 Neuroactive ligand-receptor interaction 💬
1件: PTGFR 💬 Isopropyl unoprostone 💬 Unoprostone 1件: 90 💬
134 Neuroactive ligand-receptor interaction 💬
1件: PTGFR 💬 Unoprostone 💬 Unoprostone 1件: 90 💬
135 Nitrogen metabolism 💬
13件: CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA2, CA4 💬 Acetazolamide 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
136 Nitrogen metabolism 💬
13件: CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA2, CA4 💬 Dorzolamide hydrochloride 💬 Dorzolamide 1件: 90 💬
137 Nitrogen metabolism 💬
13件: CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA2, CA4 💬 Acetazolamide sodium 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
138 Nitrogen metabolism 💬
13件: CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA2, CA4 💬 Dorzolamide 💬 Dorzolamide 1件: 90 💬
139 Non-small cell lung cancer 💬
1件: RARB 💬 Vitamin A 💬 Vitamin A 3件: 13, 53, 90 💬
140 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Omeprazole 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
141 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Omeprazole sodium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
142 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Omeprazole magnesium 💬 Omeprazole 16件:  6 , 13, 21, 46, 51, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
143 Oxytocin signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
144 Pancreatic cancer 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
145 Pancreatic secretion 💬
1件: CA2 💬 Acetazolamide 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
146 Pancreatic secretion 💬
1件: CA2 💬 Acetazolamide sodium 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
147 Pancreatic secretion 💬
1件: CA2 💬 Dorzolamide hydrochloride 💬 Dorzolamide 1件: 90 💬
148 Pancreatic secretion 💬
1件: CA2 💬 Dorzolamide 💬 Dorzolamide 1件: 90 💬
149 Parkinson disease 💬
2件: DRD1, DRD2 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
150 Pathways in cancer 💬
3件: PGF, VEGFA, VEGFB 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
151 Pathways in cancer 💬
2件: RARA, RARB 💬 Vitamin A 💬 Vitamin A 3件: 13, 53, 90 💬
152 Pathways of neurodegeneration - multiple diseases 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
153 Phospholipase D signaling pathway 💬
1件: PTGFR 💬 Isopropyl unoprostone 💬 Unoprostone 1件: 90 💬
154 Phospholipase D signaling pathway 💬
1件: PTGFR 💬 Unoprostone 💬 Unoprostone 1件: 90 💬
155 PI3K-Akt signaling pathway 💬
3件: PGF, VEGFA, VEGFB 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
156 Prion disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
157 Propanoate metabolism 💬
1件: ABAT 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
158 Propanoate metabolism 💬
1件: ABAT 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
159 Propanoate metabolism 💬
1件: ABAT 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
160 Proteoglycans in cancer 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
161 Proximal tubule bicarbonate reclamation 💬
2件: CA2, CA4 💬 Acetazolamide 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
162 Proximal tubule bicarbonate reclamation 💬
2件: CA2, CA4 💬 Acetazolamide sodium 💬 Acetazolamide 6件: 13, 90, 115, 155, 225, 230 💬
163 Proximal tubule bicarbonate reclamation 💬
2件: CA2, CA4 💬 Dorzolamide hydrochloride 💬 Dorzolamide 1件: 90 💬
164 Proximal tubule bicarbonate reclamation 💬
2件: CA2, CA4 💬 Dorzolamide 💬 Dorzolamide 1件: 90 💬
165 Rap1 signaling pathway 💬
1件: DRD2 💬 Levodopa 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
166 Rap1 signaling pathway 💬
3件: PGF, VEGFA, VEGFB 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
167 Ras signaling pathway 💬
3件: PGF, VEGFA, VEGFB 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
168 Relaxin signaling pathway 💬
2件: VEGFA, VEGFB 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
169 Renal cell carcinoma 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
170 Renin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
171 Retrograde endocannabinoid signaling 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
172 Rheumatoid arthritis 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬
173 Serotonergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
174 Small cell lung cancer 💬
1件: RARB 💬 Vitamin A 💬 Vitamin A 3件: 13, 53, 90 💬
175 Taste transduction 💬
1件: CACNA1C 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
176 Taurine and hypotaurine metabolism 💬
2件: E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
177 Taurine and hypotaurine metabolism 💬
2件: E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
178 Taurine and hypotaurine metabolism 💬
2件: E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
179 Th17 cell differentiation 💬
1件: RARA 💬 Vitamin A 💬 Vitamin A 3件: 13, 53, 90 💬
180 Tight junction 💬
1件: CACNA1D 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
181 Transcriptional misregulation in cancer 💬
1件: RARA 💬 Vitamin A 💬 Vitamin A 3件: 13, 53, 90 💬
182 Type I diabetes mellitus 💬
2件: E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
183 Type I diabetes mellitus 💬
2件: E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
184 Type I diabetes mellitus 💬
2件: E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
185 Type II diabetes mellitus 💬
2件: CACNA1C, CACNA1D 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
186 Type II diabetes mellitus 💬
1件: CACNA1G 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
187 Type II diabetes mellitus 💬
1件: CACNA1G 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
188 Type II diabetes mellitus 💬
1件: CACNA1G 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
189 Valine, leucine and isoleucine degradation 💬
1件: ABAT 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
190 Valine, leucine and isoleucine degradation 💬
1件: ABAT 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
191 Valine, leucine and isoleucine degradation 💬
1件: ABAT 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
192 Vascular smooth muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nilvadipine 💬 Nilvadipine 1件: 90 💬
193 VEGF signaling pathway 💬
1件: VEGFA 💬 Aflibercept 💬 Aflibercept 2件: 90, 166 💬